Fertility and Sterility
Volume 93, Issue 3 , Pages 697-701, February 2010

Depot medroxyprogesterone acetate use after peak bone mass is associated with increased bone turnover but no decrease in bone mineral density

  • Jennifer S. Walsh, Ph.D.

      Affiliations

    • Corresponding Author InformationReprint requests: Dr. Jennifer Walsh. Academic Unit of Bone Metabolism, Northern General Hospital, Herries Road, Sheffield, S5 7AU, United Kingdom (FAX: +44 114 2618775).
    • ,
  • Richard Eastell, M.D.
    • ,
  • Nicola F. Peel, D.M.

Academic Unit of Bone Metabolism, Northern General Hospital, Sheffield, United Kingdom

Received 3 September 2008; received in revised form 29 September 2008; accepted 3 October 2008. published online 14 November 2008.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 J.S.W. has nothing to disclose. R.E. has nothing to disclose. N.F.P. has nothing to disclose.

 This work was supported by the Arthritis Research Campaign and the National Osteoporosis Society.

PII: S0015-0282(08)04129-0

doi:10.1016/j.fertnstert.2008.10.004

Fertility and Sterility
Volume 93, Issue 3 , Pages 697-701, February 2010

Article Tools

* Image Usage & Resolution